The following is a message from Dr. Deena Hinshaw, Chief Medical Officer of Health:
Effective February 15, 2022, we will be opening up appointments for additional doses for the following age groups with certain health conditions that may put them at higher risk of severe outcomes of COVID-19:
- Adolescents 12 to 17 years of age with eligible underlying health conditions will be able to book a booster dose of the COVID-19 vaccine.
- Beginning February 15, eligible Albertans 12 to 17 years of age may book their booster dose at least five months following their last dose of a COVID-19 vaccine primary series.
- This includes those with certain immunocompromising conditions who may have received a three-dose primary series (now eligible for a fourth dose booster).
- Alberta continues to recommend that Pfizer-BioNTech Comirnaty COVID 19 vaccine be offered as the preferred choice of mRNA COVID-19 vaccine for Albertans 12 to 29 years of age to start and/or complete their primary series and for their booster dose (including immunocompromised eligible for a three-dose primary series). The Moderna (Spikevax) vaccine could be used if preferred by the patient with informed consent.
- Children 5 to 11 years of age with certain immunocompromising conditions will be eligible to book a third dose of the COVID-19 vaccine as part of a three-dose primary series.
- Booking begins on February 15, and eligible Albertans 5 to 11 years of age are recommended to schedule their third dose at least 8 weeks following their second dose of a COVID-19 vaccine.
Information and additional guidance on these changes can be found at COVID-19 Immunization. Please note updated clinical bulletins on boosters and third doses for immunocompromised children will be posted on COVID-19 Immunization later this week. In addition, all current information, including all vaccine and case data in Alberta can be found at COVID-19 Alberta statistics | alberta.ca.
Dr. Deena Hinshaw